Overview

Assessment of Long-Term Out-of-Hospital Treatment of Patients With Proximal Deep Vein Thrombosis (DVT) Using Low-Molecular-Weight Heparin (LMWH) Versus LMWH Followed by Warfarin

Status:
Completed

Trial end date:
2000-10-01

Target enrollment:

Participant gender:

Summary

The purpose of this study is to assess the long-term out-of-hospital treatment of patients with proximal venous thrombosis through the administration of subcutaneous low-molecular-weight heparin (tinzaparin sodium) versus low-molecular-weight heparin followed by warfarin sodium.

Phase:

Phase 4

Details

Lead Sponsor:

University of Calgary

Collaborators:

Canadian Institutes of Health Research (CIHR)
Dupont Applied Biosciences
LEO Pharma

Treatments:

Dalteparin
Heparin, Low-Molecular-Weight
Tinzaparin